93 1122
Pill imprint 93 1122 has been identified as Etodolac ER 400 mg.
Etodolac is used in the treatment of osteoarthritis; pain; juvenile rheumatoid arthritis; rheumatoid arthritis and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Etodolac 400 mg is not subject to the Controlled Substances Act.
See also related documents.
Etodolac ER Images
- Imprint:
-
93
1122 - Strength:
- 400 mg
- Color:
- Orange
- Size:
- 18.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
carbomer homopolymer type B
silicon dioxide
hydroxypropyl cellulose
hypromelloses
lactose monohydrate
magnesium stearate
polyethylene glycol
sodium lauryl sulfate
titanium dioxide
D&C Yellow No. 10
aluminum oxide
FD&C Red No. 40
FD&C Yellow No. 6
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-1122
| NDC Code | Manufacturer / Repackager |
|---|---|
| 16590-0092 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Etodolac ER resources
- Etodolac
- Etodolac (Wolters Kluwer)
- Etodolac Extended-Release Tablets (Wolters Kluwer)
- etodolac (Cerner Multum)
- etodolac (Micromedex) - Includes Dosage Information
- Etodolac (AHFS DI)
- Etodolac (FDA)
- Etodolac Capsules (FDA)
- Etodolac Extended-Release Tablets (FDA)
- Etodolac (Wolters Kluwer)
Search Again
